{
    "code": "56026061",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56026061",
    "time": "2020-02-26 07:30:46",
    "許可證字號": "衛部醫器輸字第026061號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/04\/16",
    "發證日期": "103\/04\/16",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA05602606102",
    "中文品名": "伯瑞 普樂斯EB病毒免疫球蛋白G檢驗試劑",
    "英文品名": "BioPlex 2200 EBV IgG",
    "效能": "本產品以多重流相免疫分析方法搭配Bio-Rad BioPlex 2200系統使用，定性方法偵測人類血清中三種不同EBV抗原-人類EB病毒核抗原-1 (Epstein-Barr Virus Nuclear Antigen-1\/EBV NA-1)、病毒外鞘抗原 (Viral Capsid Antigen\/EBV VCA)、與擴散性早期抗原 (Early Antigen diffuse\/EBV EA-D)的IgG抗體（原103年5月21日仿單標籤核定本正本收回作廢）。",
    "醫器規格": "665-1250、663-1200、663-1230。\r\n新增規格：663-1201、663-1231；規格變更：665-1250。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "C免疫學及微生物學裝置",
    "醫器主類別二": [
        "A臨床化學及臨床毒理學"
    ],
    "醫器主類別三": "A臨床化學及臨床毒理學",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "0939801100  美商伯瑞股份有限公司台灣分公司",
        "申請商地址": "台北市松山區南京東路4段126號14樓",
        "主製造廠": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "560260610003-106-08-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56026061&Seq=002&Type=9"
        },
        {
            "title": "560260610003-106-08-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56026061&Seq=002&Type=8"
        }
    ]
}